A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia
- Conditions
- CachexiaHIV InfectionsAnorexia
- Registration Number
- NCT00002067
- Lead Sponsor
- Bristol-Myers Squibb
- Brief Summary
To compare the effects of megestrol acetate and placebo on body weight, anorexia, cachexia, calorie intake, and nutritional parameters of patients with a confirmed diagnosis of AIDS. To determine whether megestrol acetate relative to placebo improves the perception of well-being among AIDS patients with cachexia. To evaluate megestrol acetate's effect on immune function via skin test reactivity, T4/T8 ratio, and total lymphocytes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (14)
Dr Mark Goldstein
🇺🇸Los Angeles, California, United States
Summitt Med Ctr / San Francisco Gen Hosp
🇺🇸Oakland, California, United States
Palo Alto Veterans Adm Med Ctr / Stanford Univ
🇺🇸Palo Alto, California, United States
Eisenhower Med Ctr
🇺🇸Rancho Mirage, California, United States
UCD Med Ctr
🇺🇸Sacramento, California, United States
San Francisco AIDS Clinic / San Francisco Gen Hosp
🇺🇸San Francisco, California, United States
San Francisco Veterans Administration Med Ctr
🇺🇸San Francisco, California, United States
Denver Public Health Dept
🇺🇸Denver, Colorado, United States
Miami Veterans Administration Med Ctr
🇺🇸Miami, Florida, United States
Univ of South Florida
🇺🇸Tampa, Florida, United States
Scroll for more (4 remaining)Dr Mark Goldstein🇺🇸Los Angeles, California, United States